2021
DOI: 10.1101/2021.10.18.464924
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Triazolopyrimidines target aerobic respiration in Mycobacterium tuberculosis

Abstract: We previously identified a series of triazolopyrimidines with anti-tubercular activity. We determined that Mycobacterium tuberculosis strains with mutations in a component of the cytochrome bc1 system (QcrB) were resistant to the series. A cytochrome bd oxidase deletion strain was also more sensitive to this series. We isolated resistant mutants, all of which had mutations in Rv1339. Compounds were active against intracellular bacteria but did not inhibit mitochondrial respiration in human HepG2 cells. These d… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 16 publications
0
1
0
Order By: Relevance
“…Finally, recent observations further suggest a link between cAMP and the electron transport chain. Isolation of spontaneous resistant mutants to a series of novel inhibitors of the QcrB subunit of the cytochrome bc1-aa3 oxidase repeatedly identify mutations in rv1339 (Chandrasekera et al, 2017;O'Malley et al, 2018;Shelton et al, 2021). How loss of rv1339 and elevated cAMP promotes resistance to QcrB inhibitors remains to be defined, but in principle could be achieved by elevated cAMP levels increasing electron transport chain activity, for example by increasing expression of the alternative terminal oxidase cytochrome bd (Ko and Oh, 2020).…”
Section: Discussionmentioning
confidence: 99%
“…Finally, recent observations further suggest a link between cAMP and the electron transport chain. Isolation of spontaneous resistant mutants to a series of novel inhibitors of the QcrB subunit of the cytochrome bc1-aa3 oxidase repeatedly identify mutations in rv1339 (Chandrasekera et al, 2017;O'Malley et al, 2018;Shelton et al, 2021). How loss of rv1339 and elevated cAMP promotes resistance to QcrB inhibitors remains to be defined, but in principle could be achieved by elevated cAMP levels increasing electron transport chain activity, for example by increasing expression of the alternative terminal oxidase cytochrome bd (Ko and Oh, 2020).…”
Section: Discussionmentioning
confidence: 99%